4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000047
EVP Strategy and Corporate Dev acquired 8,927 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-03-05 | Option exercise | +8,927 | $9.80 | $87,485 | 83,551 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacelli Steven Robert EVP Strategy and Corporate Dev | 2020-03-05 | Option exercise · Incentive Stock Option (right to buy) | −8,927 | $9.80 | 2020-03-12 | 8,927 | 0 | D: show line 2 in the form |
Loading xslF345X03/edgardoc.xml…